Cognitive impairment and psychopathology in patients with pituitary diseases

Netherlands Journal of Medicine

Volumn 70, Issue 6, 2012, Pages 255-260

  Pereira, A M ^a   Tiemensma, J ^a,b   Romijn, J A ^c   Biermasz, N R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Acromegaly; Cognition; Cushing; Pituitary adenoma; Psychopathology

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; HYDROCORTISONE; PEGVISOMANT; SOMATOSTATIN;

ACROMEGALY; ADENOMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC PAIN; COGNITIVE DEFECT; COPING BEHAVIOR; CUSHING DISEASE; FOLLOW UP; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS DISEASE; MENTAL DISEASE; MORTALITY; QUALITY OF LIFE; QUESTIONNAIRE; REMISSION; REVIEW; STRESS; PREVALENCE;

COGNITION DISORDERS; HUMANS; PITUITARY DISEASES; PREVALENCE; PSYCHOPATHOLOGY; QUALITY OF LIFE;

EID: 84871682306     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Barakat MT, Meeran K, Bloom SR. Neuroendocrine tumors [review]. Endocr Relat Cancer. 2004;11:1-18.
2. Shimon I, Melmed S. Management of pituitary tumors [review]. Ann Intern Med. 1998; 129:472-483.
3. Melmed S. Update in pituitary disease [review]. J Clin Endocrinol Metab. 2008;93:331-338.
4. Plotz CM, Knowlton AI, Ragan C. The natural history of Cushing's syndrome. Am J Med. 1952;13:597-614.
5. Roelfsema F, Biermasz NR, Pereira AM. Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary. 2012;15:71-83.
6. Honegger J, Schmalisch K, Beuschlein F, et al. Contemporary microsurgical concept for the treatment of Cushing's disease: endocrine outcome in 83 consecutive patients. Clin Endocrinol (Oxf). 2012;76:560-567.
7. Burgers AM, Kokshoorn NE, Pereira AM, et al. Low incidence of adrenal insufficiency after transsphenoidal surgery in patients with acromegaly: a long-term follow-up study. J Clin Endocrinol Metab. 2011;96:E1163-E1170.
8. Dekkers OM, Pereira AM, Roelfsema F, et al. Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab. 2006;91:1796-1801.
9. Cushing H. Psychic disturbances associated with disorders of the ductless glands. Am J Insanity. 1913;69:965-990.
10. Sonino N, Fava GA. Improving the Concept of Recovery in Endocrine Disease by Consideration of Psychosocial Issues. J Clin Endocrinol Metab. 2012, first published ahead of print May 4, 2012 as doi:10.1210/jc.2012-1710
11. Dekkers OM, Biermasz NR, Pereira AM, et al. Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab. 2007;92:976-981.
12. de Kloet ER, Joëls M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005;6:463-475.
13. Fish HR, Chernow B, O'Brian JT. Endocrine and neurophysiologic responses of the pituitary to insulin-induced hypoglycemia: a review. Metabolism. 1980;35:763-780.
14. Erturk E, Jaffe CA, Barkan AL. Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test. J Clin Endocrinol Metab. 1998;83:2350-2354.
15. Biermasz NR, van Thiel SW, Pereira AM, et al. Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab. 2004;89:5369-5376.
16. Biermasz NR, Pereira AM, Smit JW, et al. Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab. 2005;90:2731-2739.
17. van Aken MO, Pereira AM, Biermasz NR, et al. Quality of life in patients after long-term biochemical cure of Cushing's disease. J Clin Endocrinol Metab. 2005;90:3279-3286.
18. Dekkers OM, van der Klaauw AA, Pereira AM, et al. Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab. 2006;91:3364-3369.
19. van der Klaauw AA, Kars M, Biermasz NR, et al. Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clin Endocrinol (Oxf). 2008;69:775-784.
20. Pereira AM, Tiemensma J, Romijn JA. Neuropsychiatric disorders in Cushing's syndrome. Neuroendocrinology. 2010;92(Suppl 1):65-70.
21. Martignoni E, Costa A, Sinforiani E, et al. 1992 The brain as a target for adrenocortical steroids: cognitive implications. Psychoneuroendocrinology. 17:343-354.
22. Mauri M, Sinforiani E, Bono G, et al. Memory impairment in Cushing's disease. Acta Neurol Scans. 1993;87:52-55.
23. Forget H, Lacroix A, Somma M, Cohen H. Cognitive decline in patients with Cushing's syndrome. J Int Neuropsychol Soc. 2000;6:20-29.
24. Starkman MN, Giordani B, Berent S, Schork MA, Schteingart DE. Elevated cortisol levels in Cushing's disease are associated with cognitive decrements. Psychosom Med. 2001;63:985-993.
25. Michaud K, Forget H, Cohen H. Chronic glucocorticoid hypersecretion in Cushing's syndrome exacerbates cognitive aging. Brain Cogn. 2009;71:1-8.
26. Brown E S. Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Ann N Y Acad Sci. 2009;1179:41-55.
27. Fietta P, Fietta P, Delsante G. Central nervous system effects of natural and synthetic glucocorticoids. Psychiatry Clin Neurosci. 2009;63:613-622.
28. Lai Z, Roos P, Zhai O, et al. Age-related reduction of human growth hormone-binding sites in the human brain. Brain Res. 1993;621:260-266.
29. th edition. New York: McGraw-Hill, 2000.
30. Richert S, Strauss A, Lierheimer A, Eversmann T, Fahlbusch R. Psychopathology, mental functions and personality in patients with acromegaly. Acta Endocrinol (Copenh). 1983; Suppl. 253:33.
31. Richert S, Strauss A, Fahlbusch R, Oeckler R, Von Werder K. [Psychopathologic symptoms and personality traits in patients with florid acromegaly]. Schweiz Arch Neurol Psychiatr. 1987;138:61-86.
32. Flitsch J, Spitzner S, Ludecke DK. Emotional disorders in patients with different types of pituitary adenomas and factors affecting the diagnostic process. Exp Clin Endocrinol Diabetes. 2000;108:480-485.
33. Arwert LI, Veltman DJ, Deijen JB, et al. Effects of growth hormone substitution therapy on cognitive functioning in growth hormone deficient patients: a functional MRI study. Neuroendocrinology. 2006;83:12-19.
34. Koltowska-Häggström M, Mattsson AF, et al. Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalize quality of life? Eur J Endocrinol. 2006;155:109-119.
35. Biermasz NR, Pereira AM, Smit JW, Romijn JA, Roelfsema F. Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab. 2005;90:2731-2739.
36. Pereira AM, van Thiel SW, Lindner JR, et al. Increased prevalence of regurgitant valvular heart disease in acromegaly. J Clin Endocrinol Metab. 2004;89:71-75
37. Weitzner MA. Neuropsychiatry and pituitary disease: an overview [review]. Psychother Psychosom. 1998;67:125-132.
38. Weitzner MA, Kanfer S, Booth-Jones M. Apathy and pituitary disease: it has nothing to do with depression. J Neuropsychiatry Clin Neurosci. 2005;17:159-166.
39. Tiemensma J, Kokshoorn NE, Biermasz NR, et al. 2010 Subtle cognitive impairments in patients with long-term cure of Cushing's disease. J Clin Endocrinol Metab. 2010;95:2699-2714.
40. Tiemensma J, Biermasz NR, van der Mast RC, et al. Increased psychopathology and maladaptive personality traits, but normal cognitive functioning, in patients after long-term cure of acromegaly. J Clin Endocrinol Metab. 2010;95(12):E392-E402
41. Tiemensma J, Biermasz NR, Middelkoop HAM, et al. Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing's disease. J Clin Endocrinol Metab. 2010;95:E129-E141
42. Kars M, Dekkers OM, Pereira AM, Romijn JA. Update in prolactinomas [review]. Neth J Med. 2010;68:104-112.
43. Athanasoulia AP, Ising M, Pfister H, et al. District Dopaminergic Personality Patterns in Patients with Prolactinomas: A Comparison with Nonfunctioning Pituitary Adenoma Patients and Age- and Gender-Matched Controls. Neuroendocrinology. 2012 Feb 14. [Epub ahead of print]
44. Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn JA, Biermasz NR. Coping strategies in patients after treatment for functioning or nonfunctioning pituitary adenomas. J Clin Endocrinol Metab. 2011;96:964-971
45. Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn JA, Biermasz NR. Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing's syndrome. Eur J Endocrinol. 2011;165:527-535.
46. Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn JA, Biermasz NR. Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly. J Clin Endocrinol Metab. 2011;96:3550-3558